Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis

World Journal of Gastroenterology

Volumn , Issue 29, 2014, Pages 9665-9674

  Angriman, Imerio ^a   Scarpa, Marco ^b   Castagliuolo, Ignazio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Bacteria; Crohn's disease; Ileal pouch anal anastomosis; Inflammation of the ileal pouch; Inflammatory bowel disease; Microbiome; Microbiota; Pouchitis; Ulcerative colitis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; RNA 16S; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

BACTERIOLOGY; BACTERIUM; CHEMOTAXONOMY; DATA EXTRACTION; DNA POLYMORPHISM; DYSBIOSIS; FAMILIAL COLON POLYPOSIS; GENETIC ASSOCIATION; HUMAN; ILEITIS; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; META ANALYSIS (TOPIC); MICROBIAL DIVERSITY; MICROFLORA; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROCTOCOLECTOMY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ARTICLE; BACTEROIDACEAE; CLOSTRIDIACEAE; ENTEROBACTERIACEAE; FECES CULTURE; IMMUNOREGULATION; MUCOSAL IMMUNITY; POUCH MICROBIOTA; RESTORATIVE PROCTOCOLECTOMY; ADVERSE EFFECTS; COLITIS, ULCERATIVE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

BACTERIA; COLITIS, ULCERATIVE; DYSBIOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION MEDIATORS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RISK FACTORS;

EID: 84905836872     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i29.9665     Document Type: Review

References (90)

1. Onaitis MW, Mantyh C. Ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis: historical development and current status. Ann Surg 2003; 238: S42-S48 [PMID: 14703744 DOI: 10.1097/01.sla.0000098115.90865.16]
2. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995; 222: 120-127 [PMID: 7639579 DOI: 10.1097/00000658-199508000-00003]
3. Sandborn WJ, Pardi DS. Clinical management of pouchitis. Gastroenterology 2004; 127: 1809-1814 [PMID: 15578518 DOI: 10.1053/j.gastro.2004.10.011]
4. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497-500; discussion 501-502 [PMID: 8624195 DOI: 10.1001/archsurg.1996.01430170043007]
5. Svaninger G, Nordgren S, Oresland T, Hultén L. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993; 28: 695-700 [PMID: 8210985 DOI: 10.3109/00365529309098275]
6. Lovegrove RE, Tilney HS, Heriot AG, von Roon AC, Athanasiou T, Church J, Fazio VW, Tekkis PP. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum 2006; 49: 1293-1306 [PMID: 16830218 DOI: 10.1007/s10350-006-0608-0]
7. Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1: 167-174 [PMID: 3039030 DOI: 10.1007/BF01648445]
8. Parsi MA, Shen B, Achkar JP, Remzi FF, Goldblum JR, Boone J, Lin D, Connor JT, Fazio VW, Lashner BA. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004; 126: 1280-1286 [PMID: 15131788 DOI: 10.1053/j.gastro.2004.02.012]
9. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994; 69: 409-415 [PMID: 8170189 DOI: 10.1016/S0025-6196(12)61634-6]
10. Shepherd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987; 40: 601-607 [PMID: 3611389 DOI: 10.1136/jcp.40.6.601]
11. Setti Carraro PG, Talbot IC, Nicholls JR. Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study. Int J Colorectal Dis 1998; 13: 103-107 [PMID: 9638497 DOI: 10.1007/s003840050144]
12. Shepherd NA, Healey CJ, Warren BF, Richman PI, Thomson WH, Wilkinson SP. Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 1993; 34: 101-105 [PMID: 8381756 DOI: 10.1136/gut.34.1.101]
13. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology 2003; 124: 1636-1650 [PMID: 12761722]
14. Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654-662; discussion 663-665 [PMID: 9605657 DOI: 10.1097/00000658-199805000-00006]
15. Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234-239 [PMID: 8801203 DOI: 10.1136/gut.38.2.234]
16. Shepherd NA, Hultén L, Tytgat GN, Nicholls RJ, Nasmyth DG, Hill MJ, Fernandez F, Gertner DJ, Rampton DS, Hill MJ. Pouchitis. Int J Colorectal Dis 1989; 4: 205-229 [PMID: 2693561 DOI: 10.1007/BF01644986]
17. Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 622-627; discussion 627-629 [PMID: 2339922]
18. Shen B, Fazio VW, Remzi FH, Bennett AE, Lopez R, Lavery IC, Brzezinski A, Sherman KK, Lashner BA. Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. Dig Dis Sci 2007; 52: 3321-3328 [PMID: 17410449 DOI: 10.1007/s10620-006-9710-3]
19. Achkar JP, Al-Haddad M, Lashner B, Remzi FH, Brzezinski A, Shen B, Khandwala F, Fazio V. Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005; 3: 60-66 [PMID: 15645406 DOI: 10.1016/S1542-3565(04)00604-4]
20. Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu-Martin MT, Targan SR. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671-677 [PMID: 11600470 DOI: 10.1136/gut.49.5.671]
21. Lim M, Sagar P, Finan P, Burke D, Schuster H. Dysbiosis and pouchitis. Br J Surg 2006; 93: 1325-1334 [PMID: 17058325 DOI: 10.1002/bjs.5602]
22. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-917 [PMID: 11966499 DOI: 10.1046/j.1365-2036.2002.01203.x]
23. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309 [PMID: 10930365 DOI: 10.1053/gast.2000.9370]
24. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol 2000; 95: S19-S21 [PMID: 10634224 DOI: 10.1016/S0002-9270(99)00812-6]
25. Bell AJ, Nicholls RJ, Forbes A, Ellis HJ, Ciclitira PJ. Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut 2004; 53: 1801-1805 [PMID: 15542518 DOI: 10.1136/gut.2003.026807]
26. Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001; 7: 301-305 [PMID: 11720319 DOI: 10.1097/00054725-200111000-00004]
27. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 2003; 63: 453-461 [PMID: 12600225 DOI: 10.2165/00003495-200363050-00002]
28. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-114 [PMID: 14684584 DOI: 10.1136/gut.53.1.108]
29. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209 [PMID: 12730861 DOI: 10.1016/S0016-5085(03)00171-9]
30. Landy J, Al-Hassi HO, McLaughlin SD, Knight SC, Ciclitira PJ, Nicholls RJ, Clark SK, Hart AL. Etiology of pouchitis. Inflamm Bowel Dis 2012; 18: 1146-1155 [PMID: 22021180 DOI: 10.1002/ibd.21911]
31. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904 [PMID: 20664075 DOI: 10.1152/physrev.00045.2009]
32. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785 [PMID: 17699621 DOI: 10.1073/pnas.0706625104]
33. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 2005; 11: 1131-1140 [PMID: 15754393]
34. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594 [PMID: 18242222 DOI: 10.1053/j.gastro.2007.11.059]
35. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis as a prerequisite for IBD. Gut 2004; 53: 1057 [PMID: 15194668]
36. Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 2002; 46: 535-548 [PMID: 12363017 DOI: 10.1111/j.1348-0421.2002.tb02731.x]
37. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638 [PMID: 15831718 DOI: 10.1126/science.1110591]
38. Falk A, Olsson C, Ahrné S, Molin G, Adawi D, Jeppsson B. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007; 42: 973-985 [PMID: 17613928 DOI: 10.1080/00365520701204238]
39. Kohyama A, Ogawa H, Funayama Y, Takahashi K, Benno Y, Nagasawa K, Tomita S, Sasaki I, Fukushima K. Bacterial population moves toward a colon-like community in the pouch after total proctocolectomy. Surgery 2009; 145: 435-447 [PMID: 19303993 DOI: 10.1016/j.surg.2008.12.003]
40. Onderdonk AB, Dvorak AM, Cisneros RL, McLeod RS, Antionoli D, Silen W, Blair JE, Monahan-Earley RA, Cullen J, Cohen Z. Microbiologic assessment of tissue biopsy samples from ileal pouch patients. J Clin Microbiol 1992; 30: 312-317 [PMID: 1537898]
41. McLeod RS, Antonioli D, Cullen J, Dvorak A, Onderdonk A, Silen W, Blair JE, Monahan-Earley R, Cisneros R, Cohen Z. Histologic and microbiologic features of biopsy samples from patients with normal and inflamed pouches. Dis Colon Rectum 1994; 37: 26-31 [PMID: 8287743 DOI: 10.1007/BF02047210]
42. Duffy M, O'Mahony L, Coffey JC, Collins JK, Shanahan F, Redmond HP, Kirwan WO. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002; 45: 384-388 [PMID: 12068199 DOI: 10.1007/s10350-004-6187-z]
43. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosaassociated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68: 3401-3407 [PMID: 12089021 DOI: 10.1128/AEM.68.7.3401-3407.2002]
44. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. Highthroughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008; 57: 1605-1615 [PMID: 18941009 DOI: 10.1136/gut.2007.133603]
45. Zella GC, Hait EJ, Glavan T, Gevers D, Ward DV, Kitts CL, Korzenik JR. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis 2011; 17: 1092-1100 [PMID: 20845425]
46. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53: 685-693 [PMID: 15082587 DOI: 10.1136/gut.2003.025403]
47. Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13: 955-962 [PMID: 17455205 DOI: 10.1002/ibd.20151]
48. Sokol H, Lepage P, Seksik P, Doré J, Marteau P. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 2006; 44: 3172-3177 [PMID: 16954244 DOI: 10.1128/JCM.02600-05]
49. McLaughlin SD, Walker AW, Churcher C, Clark SK, Tekkis PP, Johnson MW, Parkhill J, Ciclitira PJ, Dougan G, Nicholls RJ, Petrovska L. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg 2010; 252: 90-98 [PMID: 20562611 DOI: 10.1097/SLA.0b013e3181e3dc8b]
50. Kühbacher T, Ott SJ, Helwig U, Mimura T, Rizzello F, Kleessen B, Gionchetti P, Blaut M, Campieri M, Fölsch UR, Kamm MA, Schreiber S. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006; 55: 833-841 [PMID: 16401690 DOI: 10.1136/gut.2005.078303]
51. Tannock GW, Lawley B, Munro K, Lay C, Taylor C, Daynes C, Baladjay L, Mcleod R, Thompson-Fawcett M. Comprehensive analysis of the bacterial content of stool from patients with chronic pouchitis, normal pouches, or familial adenomatous polyposis pouches. Inflamm Bowel Dis 2012; 18: 925-934 [PMID: 22114001]
52. Nasmyth DG, Godwin PG, Dixon MF, Williams NS, Johnston D. Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology 1989; 96: 817-824 [PMID: 2914643]
53. Sagar PM, Taylor BA, Godwin P, Holdsworth PJ, Johnston D, Lewis W, Miller A, Quirke P, Williamson M. Acute pouchitis and deficiencies of fuel. Dis Colon Rectum 1995; 38: 488-493 [PMID: 7736879 DOI: 10.1007/BF02148848]
54. Böhmig GA, Krieger PM, Säemann MD, Wenhardt C, Pohanka E, Zlabinger GJ. n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 1997; 92: 234-243 [PMID: 9415032 DOI: 10.1046/j.1365-2567.1997.00337.x]
55. Segain JP, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottière HM, Galmiche JP. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000; 47: 397-403 [PMID: 10940278 DOI: 10.1136/gut.47.3.397]
56. Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain JP. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis 2010; 16: 684-695 [PMID: 19774643 DOI: 10.1002/ibd.21108]
57. Scarpa M, Grillo A, Pozza A, Faggian D, Ruffolo C, Scarpa M, D'Incà R, Plebani M, Sturniolo GC, Castagliuolo I, Angriman I. TLR2 and TLR4 up-regulation and colonization of the ileal mucosa by Clostridiaceae spp. in chronic/relapsing pouchitis. J Surg Res 2011; 169: e145-e154 [PMID: 21601883 DOI: 10.1016/j.jss.2011.04.003]
58. Scarpa M, Grillo A, Faggian D, Ruffolo C, Bonello E, D' Incà R, Scarpa M, Castagliuolo I, Angriman I. Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis. Surgery 2011; 150: 56-67 [PMID: 21549404 DOI: 10.1016/j.surg.2011.02.009]
59. Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, Osborn J, Falconieri P, Borrelli O, Cucchiara S. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006; 55: 1760-1767 [PMID: 16648155 DOI: 10.1136/gut.2005.078824]
60. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2006; 44: 4136-4141 [PMID: 16988016 DOI: 10.1128/JCM.01004-06]
61. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas E, Elson CO, Hershberg RM. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005; 128: 2020-2028 [PMID: 15940634 DOI: 10.1053/j.gastro.2005.03.046]
62. Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA, Rotter JI, Landers C, Targan S. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008; 6: 561-568 [PMID: 18378498 DOI: 10.1016/j.cgh.2008.01.002]
63. Einerhand AW, Renes IB, Makkink MK, van der Sluis M, Büller HA, Dekker J. Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol 2002; 14: 757-765 [PMID: 12169985 DOI: 10.1097/00042737-200207000-00008]
64. Kyo K, Parkes M, Takei Y, Nishimori H, Vyas P, Satsangi J, Simmons J, Nagawa H, Baba S, Jewell D, Muto T, Lathrop GM, Nakamura Y. Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum Mol Genet 1999; 8: 307-311 [PMID: 9931338 DOI: 10.1093/hmg/8.2.307]
65. Parker N, Tsai HH, Ryder SD, Raouf AH, Rhodes JM. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 1995; 56: 52-56 [PMID: 7895933 DOI: 10.1159/000201222]
66. Tytgat KM, van der Wal JW, Einerhand AW, Büller HA, Dekker J. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 1996; 224: 397-405 [PMID: 8702401 DOI: 10.1006/bbrc.1996.1039]
67. Mann SD, Pitt J, Springall RG, Thillainayagam AV. Clostridium difficile infection - an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003; 46: 267-270 [PMID: 12576902 DOI: 10.1007/s10350-004-6533-1]
68. Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE, Lopez R, Queener E, Dupont HL. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008; 6: 782-788 [PMID: 18467184 DOI: 10.1007/s10620-006-9172-7]
69. Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, Ruseler-van Embden JG. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis Colon Rectum 2004; 47: 1519-1525 [PMID: 15486751 DOI: 10.1007/s10350-004-0623-y]
70. Ohge H, Furne JK, Springfield J, Rothenberger DA, Madoff RD, Levitt MD. Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005; 48: 469-475 [PMID: 15747080 DOI: 10.1007/s10350-004-0820-8]
71. Nicholls RJ, Banerjee AK. Pouchitis: risk factors, etiology, and treatment. World J Surg 1998; 22: 347-351 [PMID: 9523515 DOI: 10.1007/s002689900395]
72. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 2005; 54: 1182-1193 [PMID: 15840688 DOI: 10.1136/gut.2004.062794]
73. Haller D, Russo MP, Sartor RB, Jobin C. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem 2002; 277: 38168-38178 [PMID: 12140289 DOI: 10.1074/jbc.M205737200]
74. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol 1994; 6: 584-589 [PMID: 7946046 DOI: 10.1016/0952-7915(94)90145-7]
75. Fellermann K, Stange EF. Defensins - innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 2001; 13: 771-776 [PMID: 11474305 DOI: 10.1097/00042737-200107000-00003]
76. Toiyama Y, Araki T, Yoshiyama S, Hiro J, Miki C, Kusunoki M. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today 2006; 36: 287-290 [PMID: 16493544 DOI: 10.1007/s00595-005-3144-y]
77. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989; 84: 553-561 [PMID: 2668334 DOI: 10.1172/JCI114198]
78. Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990; 87: 210-214 [PMID: 1688654 DOI: 10.1073/pnas.87.1.210]
79. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996; 271: 2935-2940 [PMID: 8621683 DOI: 10.1074/jbc.271.6.2935]
80. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992; 267: 23216-23225 [PMID: 1429669]
81. Cunliffe RN, Rose FR, Keyte J, Abberley L, Chan WC, Mahida YR. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001; 48: 176-185 [PMID: 11156637 DOI: 10.1136/gut.48.2.176]
82. Wehkamp J, Schwind B, Herrlinger KR, Baxmann S, Schmidt K, Duchrow M, Wohlschläger C, Feller AC, Stange EF, Fellermann K. Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci 2002; 47: 1349-1355 [PMID: 12064812 DOI: 10.1023/A:1015334917273]
83. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445-456 [PMID: 11181568 DOI: 10.1093/hmg/10.5.445]
84. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 6718-6724 [PMID: 10586069]
85. Kiehne K, Brunke G, Wegner F, Banasiewicz T, Folsch UR, Herzig KH. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006; 12: 1056-1062 [PMID: 16534846]
86. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schröder JM. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000; 22: 714-721 [PMID: 10837369 DOI: 10.1165/ajrcmb.22.6.4023]
87. McLaughlin SD, Clark SK, Shafi S, Petrovska L, Tekkis PP, Ciclitira PJ, Nicholls RJ. Fecal coliform testing to identify effective antibiotic therapies for patients with antibioticresistant pouchitis. Clin Gastroenterol Hepatol 2009; 7: 545-548 [PMID: 19418603 DOI: 10.1016/j.cgh.2009.01.002]
88. Scarpa M, Grillo A, Scarpa M, Brun P, Castoro C, Pozza A, Cavallo D, Faggian D, Ruffolo C, D'Incà R, Bardini R, Castagliuolo I, Angriman I. Innate immune environment in ileal pouch mucosa: á5 defensin up-regulation as predictor of chronic/relapsing pouchitis. J Gastrointest Surg 2012; 16: 188-201; discussion 201-202 [PMID: 21983950 DOI: 10.1007/s11605-011-1720-6]
89. Komanduri S, Gillevet PM, Sikaroodi M, Mutlu E, Keshavarzian A. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007; 5: 352-360 [PMID: 17368235 DOI: 10.1016/j.cgh.2007.01.001]
90. Tyler AD, Knox N, Kabakchiev B, Milgrom R, Kirsch R, Cohen Z, McLeod RS, Guttman DS, Krause DO, Silverberg MS. Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One 2013; 8: e66934 [PMID: 24086242 DOI: 10.1371/journal.pone.0066934]